Turing Pharmaceuticals AG announced its official launch along with news of three acquisitions for its commercial operations and development pipeline. The company also introduced its senior management team. New York-based Turing will focus on developing and commercializing treatments for serious diseases and conditions across a broad range of therapeutic areas, for which there are currently limited or no treatment options. Turing’s founder and executive chairman is Martin Shkreli, founder a...